199 related articles for article (PubMed ID: 24736592)
1. Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease.
Toschi L; Finocchiaro G; Nguyen TT; Skokan MC; Giordano L; Gianoncelli L; Perrino M; Siracusano L; Di Tommaso L; Infante M; Alloisio M; Roncalli M; Scorsetti M; Jänne PA; Santoro A; Varella-Garcia M
PLoS One; 2014; 9(4):e95303. PubMed ID: 24736592
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer.
Tran TN; Selinger CI; Kohonen-Corish MRJ; McCaughan BC; Kennedy CW; O'Toole SA; Cooper WA
Lung Cancer; 2013 Sep; 81(3):462-467. PubMed ID: 23806793
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of PIK3CA and SOX2 in Asian patients with lung squamous cell carcinoma.
Iijima Y; Seike M; Noro R; Ibi T; Takeuchi S; Mikami I; Koizumi K; Usuda J; Gemma A
Int J Oncol; 2015 Feb; 46(2):505-12. PubMed ID: 25384882
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological and Survival Analysis of Japanese Patients with Resected Non-Small-Cell Lung Cancer Harboring NKX2-1, SETDB1, MET, HER2, SOX2, FGFR1, or PIK3CA Gene Amplification.
Inoue Y; Matsuura S; Kurabe N; Kahyo T; Mori H; Kawase A; Karayama M; Inui N; Funai K; Shinmura K; Suda T; Sugimura H
J Thorac Oncol; 2015 Nov; 10(11):1590-600. PubMed ID: 26536195
[TBL] [Abstract][Full Text] [Related]
5. FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer.
Seo AN; Jin Y; Lee HJ; Sun PL; Kim H; Jheon S; Kim K; Lee CT; Chung JH
Virchows Arch; 2014 Nov; 465(5):547-58. PubMed ID: 25086725
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.
Kim HR; Kim DJ; Kang DR; Lee JG; Lim SM; Lee CY; Rha SY; Bae MK; Lee YJ; Kim SH; Ha SJ; Soo RA; Chung KY; Kim JH; Lee JH; Shim HS; Cho BC
J Clin Oncol; 2013 Feb; 31(6):731-7. PubMed ID: 23182986
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer.
Cihoric N; Savic S; Schneider S; Ackermann I; Bichsel-Naef M; Schmid RA; Lardinois D; Gugger M; Bubendorf L; Zlobec I; Tapia C
Br J Cancer; 2014 Jun; 110(12):2914-22. PubMed ID: 24853178
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression of SOX2 and FGFR1 in correlation with poor prognosis in patients with small cell lung cancer.
Yang F; Gao Y; Geng J; Qu D; Han Q; Qi J; Chen G
Int J Clin Exp Pathol; 2013; 6(12):2846-54. PubMed ID: 24294370
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical overexpression of platelet-derived growth factor receptor-beta (PDGFR-β) is associated with PDGFRB gene copy number gain in sarcomatoid non-small-cell lung cancer.
Tsao AS; Wei W; Kuhn E; Spencer L; Solis LM; Suraokar M; Lee JJ; Hong WK; Wistuba II
Clin Lung Cancer; 2011 Nov; 12(6):369-74. PubMed ID: 21729646
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor 1 amplification in non-small cell lung cancer by quantitative real-time PCR.
Gadgeel SM; Chen W; Cote ML; Bollig-Fischer A; Land S; Schwartz AG; Bepler G
PLoS One; 2013; 8(11):e79820. PubMed ID: 24255716
[TBL] [Abstract][Full Text] [Related]
11. Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer.
Samulin Erdem J; Skaug V; Bakke P; Gulsvik A; Haugen A; Zienolddiny S
BMC Cancer; 2016 Jan; 16():28. PubMed ID: 26780934
[TBL] [Abstract][Full Text] [Related]
12. Association of SOX2 and Nestin DNA amplification and protein expression with clinical features and overall survival in non-small cell lung cancer: A systematic review and meta-analysis.
Li Q; Liu F; Zhang Y; Fu L; Wang C; Chen X; Guan S; Meng X
Oncotarget; 2016 Jun; 7(23):34520-31. PubMed ID: 27150062
[TBL] [Abstract][Full Text] [Related]
13. PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: A comprehensive mutational analysis from a multi-institutional cohort.
Sawa K; Koh Y; Kawaguchi T; Kambayashi S; Asai K; Mitsuoka S; Kimura T; Yoshimura N; Yoshimoto N; Kubo A; Saka H; Matsumura A; Wanibuchi H; Yamamoto N; Nishiyama N; Hirata K
Lung Cancer; 2017 Oct; 112():96-101. PubMed ID: 29191607
[TBL] [Abstract][Full Text] [Related]
14. High MET gene copy number leads to shorter survival in patients with non-small cell lung cancer.
Go H; Jeon YK; Park HJ; Sung SW; Seo JW; Chung DH
J Thorac Oncol; 2010 Mar; 5(3):305-13. PubMed ID: 20107422
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of fibroblast growth factor receptor 1 gene locus amplification in resected lung squamous cell carcinoma.
Craddock KJ; Ludkovski O; Sykes J; Shepherd FA; Tsao MS
J Thorac Oncol; 2013 Nov; 8(11):1371-7. PubMed ID: 24077455
[TBL] [Abstract][Full Text] [Related]
16. FGFR1 expression and gene copy numbers in human lung cancer.
Kohler LH; Mireskandari M; Knösel T; Altendorf-Hofmann A; Kunze A; Schmidt A; Presselt N; Chen Y; Petersen I
Virchows Arch; 2012 Jul; 461(1):49-57. PubMed ID: 22648708
[TBL] [Abstract][Full Text] [Related]
17. PIK3CA mutations frequently coexist with EGFR/KRAS mutations in non-small cell lung cancer and suggest poor prognosis in EGFR/KRAS wildtype subgroup.
Wang L; Hu H; Pan Y; Wang R; Li Y; Shen L; Yu Y; Li H; Cai D; Sun Y; Chen H
PLoS One; 2014; 9(2):e88291. PubMed ID: 24533074
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the clinical relevance of 17q25.3 copy number and three-dimensional telomere organization in non-small lung cancer patients.
Sunpaweravong P; Thu KL; Lam WL; Mai S
J Cancer Res Clin Oncol; 2016 Apr; 142(4):749-56. PubMed ID: 26621152
[TBL] [Abstract][Full Text] [Related]
19. Genetic alteration profiling of patients with resected squamous cell lung carcinomas.
Tao D; Han X; Zhang N; Lin D; Wu D; Zhu X; Song W; Shi Y
Oncotarget; 2016 Jun; 7(24):36590-36601. PubMed ID: 27145277
[TBL] [Abstract][Full Text] [Related]
20. PIK3CA mutations as prognostic factor in squamous cell lung carcinoma.
McGowan M; Hoven AS; Lund-Iversen M; Solberg S; Helland Å; Hirsch FR; Brustugun OT
Lung Cancer; 2017 Jan; 103():52-57. PubMed ID: 28024696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
